KPRX — Kiora Pharmaceuticals Share News
0.000.00%
Last trade - 00:00EyeGate Pharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview
EyeGate Pharmaceuticals Inc expected to post a loss of 42 cents a share - Earnings Preview
EyeGate Pharma names new CEO, shares surge
Brief: EyeGate Pharma Reports Appointment of Brian M. Strem as President and CEO
Brief: Eyegate Pharma Announces First Patient Dosed For Pp-001 In A Phase 2 Proof-Of-Concept Ocular Surface Inflammation Study
EyeGate Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Eyegate Pharma Reports First Quarter 2021 Financial Results
Brief: Eyegate Pharmaceuticals Files Prospectus Related To Offering Of 3.9 Million Shares Of Common Stock Of Co By Selling Stockholders - SEC Filing
Brief: EyeGate Pharmaceuticals Announces Management Transition In Support Of Strategic Transformation
Brief: EyeGate Enters Into Agreement For $8 Mln Private Placement
U.S. RESEARCH ROUNDUP-HMS Holdings, Illumina, RealPage
U.S. STOCKS ON THE MOVE-Tesla, RealPage, Eyegate Pharmaceuticals
EyeGate Pharma: More than doubles on buying eye-disease focused Panoptes Pharma
Brief: Eyegate Pharma Announces Transformative Acquisition Of Panoptes Pharma
NASDAQ RESUMED AT 10:11 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:06 AM
Brief: EyeGate Pharma To Proceed With PE Pivotal Study
Brief: EyeGate Pharma - Appointed Keith Maher As Class III Director To Fill Vacancy Created By Resignation Of Peter Greenleaf
EyeGate Pharma: Falls on stock offering